Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Insurance and Capital Markets Companies Q3FY21 Results Preview - Stronger earnings expected across sectors - HDFC Securities

Posted On: 2021-01-12 03:23:43 (Time Zone: Arizona, USA)


Asset management. While active equity has witnessed net outflows of Rs 566.9bn in FY21TD with 3QFY21 accounting for Rs 436.0bn, Nifty-50/Nifty-200 are up 24.3/23.6% just in 3QFY21; this has driven industry equity AUM higher by 16.4% QoQ. Debt schemes continued to receive inflows with 3QFY21 witnessing Rs 1.45tn vs. Rs 818bn in 2QFY21. Higher equity prices are expected to boost treasury profits. Commentary from management around flows and market share will be key. Our top pick in the space is UTIAM. We maintain BUY rating with a TP of Rs 650 (i.e. 20.6x Sep-22E NOPLAT + cash and investments).

Broking. Despite introducing the first phase of upfront peak margin requirement for cash and derivatives, ADTV for cash increased 57.1/-0.8% YoY/QoQ, while derivatives saw a growth of 77.6/38.1%. We expect family-owned smaller scale brokers to cede market share to more organized larger competitors. Strong activity along with market share gain is expected to boost broking revenues. Distribution income is expected to improve as industry active equity AUM grew 8.1/16.4% YoY/QoQ. Commentary around new customer acquisition, new pricing plans, and the impact of regulatory changes will be key to watch. ISEC: We expect ISEC to deliver APAT growth of 77.1/-12.6 % YoY/QoQ. We retain ADD with a TP of Rs 560 (i.e. 23x Sep-22E EPS).

General Insurance. GDPI (ex. crop) growth for the sector improved in the first 2 months of 3QFY21 by +6.3/7.7% YoY/QoQ. The two large segments- Health/Motor grew 3.8/4.8% YoY. We expect a slight deterioration in loss ratios in segments other than health as business activity resumed. We expect a slightly higher loss ratio for the health segment as COVID-19 related claims and elective surgeries increased. We expect lower interest rates to impact investment income, while FV change accounts should see increased unrealised gains as equity prices improved. Commentary around health and motor claims will be key to watch. ICICIGI: Over FY21E, we expect lockdown and partial working conditions to result in lower top-line growth, but improved CORs on a YoY basis. We maintain REDUCE on ICICIGI with an increased TP of Rs 1,210 (Sep-22E P/E of 27.6x and a P/ABV of 5.5x) as valuations are high and the market is ignoring risks on lower price hikes and potential de-tarification action for motor TP.

Life insurance. Pvt. life insurers' reported an indiv. APE growth of 2.7% YoY in 3QFY21 vs. decline of 3.0% YoY in 2QFY21. Savings business growth returned over the quarter, as indicated by the non-single premium sum assured / premium ratio moderation to 25.3 (-6.7% QoQ, upto Nov-20). Channel checks indicate that NPAR and PAR product sales continue to do well, while ULIP sales are improving. Protection in mix is expected to moderate. Group APE continues to do well for private insurers as 3QFY21 reported growth of 30.7% YoY. Commentary around potential impact of new PF regulations on insurance investments, and lower interest rates on NPAR savings products will be key. Our preferred picks are SBILIFE and MFSL with BUY and ADD ratings and higher TPs of Rs 1,140 and Rs 800, respectively.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

4th Industrial Conclave - Bullish undertone, favourable valuation - HDFC Securities

Sanofi India - Weak quarter; sequential improvement - ICICI Securities

Sunteck Realty - All eyes on upcoming launches - ICICI Securities

Company Update - Tata Motors - ICICI Direct

Q4CY20 Company Update - Mahindra CIE Automotive - ICICI Direct

Event Update - Hindalco - ICICI Direct

EY report launch at BioAsia 2021 - Moving the needle: Healthcare industry in a post-COVID world

Initiating Coverage - Dalmia Bharat Ltd - HDFC Securities Retail Research Desk

Initiating Coverage - Mastek Ltd - HDFC Securities Retail Research Desk

Hindalco Industries - Status quo maintained - ICICI Securities

Tata Motors - India business scaling in the right direction - ICICI Securities

IPO Review - Heranba Industries Ltd

Company Update - Narayana Hrudayalaya - ICICI Direct

Ambuja Cements - Market share sustenance key for rerating - ICICI Securities

ADD on Astral Poly Technik - An 'astr'onomical growth story - HDFC Securities

FMCG Sector Update Report - Divergence narrows; refocus on core - HDFC Securities

Maintain REDUCE on Jubilant FoodWorks - More legs for growth; reflecting confidence on core - HDFC Securities

Torrent Power - Growth acceleration - ICICI Securities

Mahindra CIE Automotive - CY20 performance closes on a strong note - ICICI Securities

Q3FY21 Company Update - V-Guard Industries - ICICI Direct

Quant Pick - Indus Towers - ICICI Direct

Q4CY20 Result Update - Ambuja Cement - ICICI Direct

Q3FY21 Company Update - Nesco Ltd - ICICI Direct

Maintain BUY on Ambuja Cements - Healthy quarter; multiple triggers ahead - HDFC Securities

Heranba Industries Ltd. - IPO - Sound Financials & Promising Outlook Augur Well

India Equity Strategy Report - Quarterly flipbook: Q3 - upgrades galore! - HDFC Securities

Earnings Wrap Q3FY21: Encouraging quarter, broad based recovery under way!

Shilpa Medicare - USFDA import alert at Jadcherla unit - ICICI Securities

Q3FY21 Company Update - Indian Bank - ICICI Direct

Quant Pick - Torrent Power - ICICI Direct

GE T&D India - Strong cashflow - ICICI Securities

Q3FY21 Result Update - Graphite India - ICICI Direct

Q4CY2020 Result Update - Varun Beverages - ICICI Direct

Q3FY21 Company Update - NBCC Ltd - ICICI Direct

Quant Pick - United Breweries - ICICI Direct

Q4CY2020 Result Update - Nestlé India - ICICI Direct

Q3FY21 Result Update - Time Technoplast - ICICI Direct

Healthy Business Performance Puts ITC Stock Recovery on Track

Gold - Feb 17, 2021 - Reliance Securities

Maintain REDUCE on Nestle India - Steady revenue show; employee cost dents margins - HDFC Securities

Varun Beverages - Q4 CY20 Result and Concall Update - YES Securities

Nestle India - Q4 CY20 Result Update - YES Securities

Reiterate BUY on JMC Projects - Some hits, some misses - HDFC Securities

Varun Beverages - Strong volumes; higher margins - ICICI Securities

Computer Age Management Services - Play on industry AUM growth - ICICI Securities

Nestle India - Just a tad underwhelming (given the high benchmarks expected from Nestle India) - ICICI Securities

NHPC - Earnings robust; projects on track - ICICI Securities

Maintain BUY on ITD Cementation - Gradual recovery shaping up - HDFC Securities

Techno Electric & Engineering - Strong margins, healthy growth outlook - ICICI Securities

Time Technoplast - Outlook upbeat; execution remains key - ICICI Securities



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020